Clinical Trial Update: Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis [Phase 1]

View source ↗

Summary

A Phase 1 safety study of a gene therapy drug for familial hypertriglyceridemia with recurrent pancreatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Pancreatitis

Drugs mentioned

• Gene therapy drug

Snippet

Sponsor: GeneCradle Inc | Conditions: Hypertriglyceridemia, Familial | Phase 1 | Status: RECRUITING